19 June 2026 in Journal of Intensive Care Medicine
Background: Accurate assessment of organ dysfunction is essential for risk stratification in critically ill patients. The traditional Sequential Organ Failure Assessment score (SOFA-1) is widely used but reflects clinical practices from the 1990s. The updated SOFA-2 incorporates revised thresholds aligned with current organ-support strategies; however, its prognostic performance in infection-focused intensive care unit (ICU) populations remains uncertain. We compared SOFA-1 and SOFA-2 for predicting 28-day mortality in ICU patients undergoing blood culture acquisition ≥48 h after admission. Methods: We conducted a retrospective cohort study of adult ICU patients who underwent blood culture sampling ≥48 h after ICU admission between June 2022 and August 2024. SOFA-1 and SOFA-2 scores were calculated at the time of index blood culture. Mortality prediction was assessed using receiver operating characteristic analysis with paired DeLong comparisons. Associations with 28-day mortality were examined using logistic regression and Cox proportional hazards models adjusted for age and comorbidity burden. Clinical utility was evaluated using decision curve analysis. Results: Among 403 patients, 28-day mortality was 54%. SOFA-2 scores were lower than SOFA-1 in 70% of patients, resulting in frequent downward reclassification across severity strata. Discriminative performance for 28-day mortality was similar for SOFA-1 and SOFA-2 (AUC 0.707 vs 0.700; ΔAUC = 0.007; p = .031). Calibration and net clinical benefit were comparable between scores. In adjusted time-to-event analyses, only the very severe category (>10) was independently associated with mortality in both scoring systems, with a numerically higher hazard ratio for SOFA-2. Conclusions: In this infection-triggered ICU cohort, SOFA-2 did not demonstrate consistent prognostic superiority over SOFA-1 for 28-day mortality prediction. Despite systematic score redistribution, overall discrimination and clinical utility were similar, with any apparent advantage of SOFA-2 confined to the highest-risk subgroup. Further validation in infection-enriched ICU populations is warranted.
14 September 2026 in npj Digital Medicine
Bacteremia is a life-threatening infection requiring early diagnosis and timely treatment. Although machine learning (ML)–based models may support early clinical decision-making, their validity remains uncertain. We prospectively validated ML-based models developed at our center for predicting Gram-negative bacteremia and compared their performance with established clinical scores. This observational study included adult ICU patients hospitalized for ≥48 h who met Sepsis-3 criteria for suspected infection between February and July 2025. Clinical and laboratory data from the preceding 48 h were analyzed. Gram-negative bacteremia was identified in 97 of 289 blood cultures. Several clinical scores were significantly associated with bacteremia. While ML models demonstrated modest discrimination in cohort, performance improved to a moderate level (AUROC ≈ 0.70) with higher sensitivity in a post-hoc subgroup analysis of cultures obtained between ICU days 4 and 10. These findings highlight the importance of patient stratification and culture selection when validating predictive models in clinical settings.
28 July 2026 in Current HIV Research
Introduction/Objective: HIV infection has transitioned from a fatal disease to a man-ageable chronic condition due to effective antiretroviral therapy (ART). While life expectancy has increased, there is a growing need to assess health-related quality of life (HRQoL) as part of comprehensive HIV care. This study evaluated changes in HRQoL during the first six months after diagnosis among individuals newly diagnosed with HIV. Methods: This prospective observational study was conducted at a tertiary care hospital in Tü-rkiye and included 81 newly diagnosed adults living with HIV. HRQoL was assessed using the WHOQOL-HIV Bref scale at baseline (n = 81), month 3 (n = 70), and month 6 (n = 81). Longitudinal changes were analysed using repeated-measures ANOVA or Friedman tests, with paired t-tests or Wilcoxon signed-rank tests for pairwise comparisons, as appropriate. The Minimal Clinically Important Difference (MCID) was calculated using anchor-based and distribution-based methods, and logistic regression was used to examine factors associated with anchor-defined perceived clinical improvement. Results: The overall HRQoL score increased from 14.12 at baseline to 14.80 at month 3 and 14.90 at month 6. Significant improvements over the six-month period were observed in physical health (p = 0.006), environment (p = 0.011), and overall HRQoL (p = 0.021). Higher overall HRQoL scores were associated with greater odds of anchor-defined perceived clinical improvement (CI+) at month 3 (OR = 2.34, 95% CI: 1.56–4.03, p < 0.001) and month 6 (OR = 2.39, 95% CI: 1.52–4.60, p = 0.002). Discussion: These findings suggest that HRQoL may improve during early follow-up after HIV diagnosis and initiation of ART, particularly in physical health. Early HRQoL assessment may also complement virological monitoring by capturing patient-centred information during the first months after HIV diagnosis. Conclusion: Beyond treatment access and virological suppression, improving HRQoL should be considered an important goal in HIV care. Strengthening social support systems, reducing stigma, and integrating multidisciplinary approaches may help support progress towards the Fourth 90 targets.